0001209191-19-039245.txt : 20190627
0001209191-19-039245.hdr.sgml : 20190627
20190627161057
ACCESSION NUMBER: 0001209191-19-039245
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190625
FILED AS OF DATE: 20190627
DATE AS OF CHANGE: 20190627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szela Mary T
CENTRAL INDEX KEY: 0001410289
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 19925418
MAIL ADDRESS:
STREET 1: 10835 ROAD TO THE CURE
STREET 2: SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3033 SCIENCE PARK ROAD, SUITE 220
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 3033 SCIENCE PARK ROAD, SUITE 220
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-25
0
0001422143
Kura Oncology, Inc.
KURA
0001410289
Szela Mary T
C/O KURA ONCOLOGY, INC.
3033 SCIENCE PARK ROAD, SUITE 220
SAN DIEGO
CA
92121
1
0
0
0
Option to purchase common stock
19.55
2019-06-25
4
A
0
13000
0.00
A
2029-06-24
Common Stock
13000
13000
D
This option vests in full on the one year anniversary of the date of grant.
Marc Grasso, M.D., Attorney-in-fact for Mary Szela
2019-06-27